CYCLONE 3: A Phase 3, randomized, double-blind, placebo-controlled study of abemaciclib in combination with abiraterone plus prednisone in men with high-risk metastatic hormone-sensitive prostate cancer (mHSPC)

Saved in:
Bibliographic Details
Published in:European urology 2023-02, Vol.83, p.S757
Main Authors: Piulats, J.M., Smith, M., Matsubara, N., Zhang, T., Agarwal, N., Mckay, R.R., Johnston, E., Sherwood, S., Schaverien, C., Fasnacht, N., Lithio, A., Nacerddine, K., Todenhöfer, T.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(23)00577-8